TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Brief Summary: The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.


Options:
A: Arm Label: Varenicline + Placebo Patch; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Drug: Placebo Patch, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Arm Label: Nicotine Patch + Placebo Tablet; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch, Drug: Placebo Tablet, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: DRUG; Name: Placebo Patch; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Placebo Tablet; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: BEHAVIORAL; Name: Questionnaires; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: BEHAVIORAL; Name: Counseling Sessions; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Lab Session; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Saliva Test; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch
B: Arm Label: 1 Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: 2 Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): 1 Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 Placebo
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline Tartarate | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Varenicline Tartarate; Assigned to Arm(s): varenicline

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Brief Summary: The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.


Options:
A: Arm Label: Varenicline pre-treatmemt; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline, Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Placebo, Varenicline pre-treatmemt | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Varenicline + Placebo Patch; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Drug: Placebo Patch, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Arm Label: Nicotine Patch + Placebo Tablet; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch, Drug: Placebo Tablet, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: DRUG; Name: Placebo Patch; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Placebo Tablet; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: BEHAVIORAL; Name: Questionnaires; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: BEHAVIORAL; Name: Counseling Sessions; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Lab Session; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Saliva Test; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch
C: Arm Label: Extended treatment; Type: EXPERIMENTAL; Interventions: Drug: varenicline, Behavioral: Individual smoking cessation counseling | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline, Behavioral: Individual smoking cessation counseling | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): Extended treatment, Standard treatment | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): Extended treatment, Standard treatment | Intervention Type: BEHAVIORAL; Name: Individual smoking cessation counseling; Assigned to Arm(s): Extended treatment, Standard treatment
D: Arm Label: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Brief Summary: The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Champix | Intervention Type: DRUG; Name: Champix; Assigned to Arm(s): Placebo
B: Arm Label: Varenicline + Placebo Patch; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Drug: Placebo Patch, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Arm Label: Nicotine Patch + Placebo Tablet; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch, Drug: Placebo Tablet, Behavioral: Questionnaires, Behavioral: Counseling Sessions, Other: Lab Session, Other: Saliva Test | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: DRUG; Name: Placebo Patch; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Placebo Tablet; Assigned to Arm(s): Nicotine Patch + Placebo Tablet | Intervention Type: BEHAVIORAL; Name: Questionnaires; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: BEHAVIORAL; Name: Counseling Sessions; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Lab Session; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch | Intervention Type: OTHER; Name: Saliva Test; Assigned to Arm(s): Nicotine Patch + Placebo Tablet, Varenicline + Placebo Patch
C: Arm Label: Drug Selegiline; Type: EXPERIMENTAL; Interventions: Drug: Selegiline | Arm Label: Matching placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: matching placebo | Intervention Type: DRUG; Name: Selegiline; Assigned to Arm(s): Drug Selegiline | Intervention Type: OTHER; Name: matching placebo; Assigned to Arm(s): Matching placebo
D: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Matched Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo for varenicline | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo for varenicline; Assigned to Arm(s): Matched Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Vitamin E Fortified Whey Drink on Nutritional Status, Inflammatory Markers and Oxidative Stress in Hemodialysis Patients
Brief Summary: The purpose of the study is to evaluate the effect of vitamin E fortified whey drink on nutritional status, inflammatory markers and oxidative stress in hemodialysis patients


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nepro nutritional supplement | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Nepro nutritional supplement; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: activity group; Type: EXPERIMENTAL; Interventions: Device: Exercise training in addition to nutritional support | Intervention Type: DEVICE; Name: Exercise training in addition to nutritional support; Assigned to Arm(s): activity group
C: Arm Label: treated group; Type: EXPERIMENTAL; Interventions: Other: training on ergonomic bicycle, Drug: Testosterone, Drug: Oral nutritional supplementation, Drug: n3 polyunsaturated fatty acid | Arm Label: control group; Type: OTHER; Interventions: Drug: Oral nutritional supplementation | Intervention Type: OTHER; Name: training on ergonomic bicycle; Assigned to Arm(s): treated group | Intervention Type: DRUG; Name: Testosterone; Assigned to Arm(s): treated group | Intervention Type: DRUG; Name: Oral nutritional supplementation; Assigned to Arm(s): control group, treated group | Intervention Type: DRUG; Name: n3 polyunsaturated fatty acid; Assigned to Arm(s): treated group
D: Arm Label: whey drink; Type: EXPERIMENTAL; Interventions: Dietary Supplement: whey drink, | Arm Label: whey drink fortified with vitaminE; Type: EXPERIMENTAL; Interventions: Dietary Supplement: whey drink fortified with vitaminE | Arm Label: vitaminE; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin E | Arm Label: D- control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: whey drink,; Assigned to Arm(s): whey drink | Intervention Type: DIETARY_SUPPLEMENT; Name: whey drink fortified with vitaminE; Assigned to Arm(s): whey drink fortified with vitaminE | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin E; Assigned to Arm(s): vitaminE

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: 200699: A Clinical Study to Evaluate Four Doses of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component
Brief Summary: The purpose of this study is to evaluate the dose-response of 4 doses of umeclidinium bromide in combination with fluticasone furoate compared with fluticasone furoate monotherapy in chronic obstructive pulmonary disease participants with an asthmatic component. The fluticasone furoate/umeclidinium bromide treatments will also be compared to the once-daily inhaled corticosteroid/long-acting beta agonist combination fluticasone furoate/vilanterol.


Options:
A: Arm Label: Fluticasone furoate/GW642444; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/GW642444 | Arm Label: fluticasone furoate; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone furoate | Intervention Type: DRUG; Name: Fluticasone Furoate/GW642444; Assigned to Arm(s): Fluticasone furoate/GW642444 | Intervention Type: DRUG; Name: Fluticasone furoate; Assigned to Arm(s): fluticasone furoate
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: inhaled corticosteroid(ICS)/long acting bronchodilator (LABA); Type: ACTIVE_COMPARATOR; Interventions: Drug: FF/Vilanterol (VI; GW642444M) | Arm Label: ICS; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Furoate | Intervention Type: DRUG; Name: Fluticasone Furoate; Assigned to Arm(s): ICS | Intervention Type: DRUG; Name: FF/Vilanterol (VI; GW642444M); Assigned to Arm(s): inhaled corticosteroid(ICS)/long acting bronchodilator (LABA) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: FF/VI 200/25mcg once daily; Type: EXPERIMENTAL; Interventions: Drug: GW685698/GW642444 | Arm Label: Fluticasone propionate 500mcg twice daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: CCI18781 | Intervention Type: DRUG; Name: GW685698/GW642444; Assigned to Arm(s): FF/VI 200/25mcg once daily | Intervention Type: DRUG; Name: CCI18781; Assigned to Arm(s): Fluticasone propionate 500mcg twice daily
D: Arm Label: Treatment Phase A; Type: EXPERIMENTAL; Interventions: Drug: FF, Drug: UMEC, Drug: VI | Arm Label: Treatment Phase B; Type: EXPERIMENTAL; Interventions: Drug: FF, Drug: UMEC, Drug: VI | Arm Label: Treatment Phase C; Type: EXPERIMENTAL; Interventions: Drug: FF, Drug: UMEC, Drug: VI | Intervention Type: DRUG; Name: FF; Assigned to Arm(s): Treatment Phase A, Treatment Phase B, Treatment Phase C | Intervention Type: DRUG; Name: UMEC; Assigned to Arm(s): Treatment Phase A, Treatment Phase B, Treatment Phase C | Intervention Type: DRUG; Name: VI; Assigned to Arm(s): Treatment Phase A, Treatment Phase B, Treatment Phase C

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sinovuyo Caring Families Project
Brief Summary: It has been established that children in families affected by either intimate partner violence or Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) are at substantially increased risk of poor parenting and child maltreatment. In the sub-Saharan African context of high levels of HIV/AIDS and family violence, it is crucial that parents be supported to establish positive parenting practices and reduce harsh or abusive parenting within their families.This randomized controlled trial will be testing the Sinovuyo Caring Families Program (n = 296), a 12-session (2.5 hour per session) parenting intervention for primary caregivers of children between 2 and 9 years old. Participants will not be restricted to biological parents and include primary caregivers of children between 2 and 9 years old, who live in the same house as the child at least 4 nights per week. Participants will be recruited through systematic household sampling, liaising with Western Cape Department of Social Development and local community-based NGOs. Self-reporting questionnaires and qualitative observational assessment data for intervention and control groups will be collected at pre- and post-test evaluation as well as 12-month follow-up. Primary outcomes will include child behaviour problems, harsh and inconsistent parenting and positive parenting. Secondary outcomes will include parental depression, parental stress, parental monitoring and supervision and parent perceived social support.


Options:
A: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
B: Arm Label: E-CAU with Group Problem Management Plus (PM+); Type: EXPERIMENTAL; Interventions: Behavioral: Problem Management Plus (PM+) | Arm Label: Enhanced care as usual (E-CAU) only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem Management Plus (PM+); Assigned to Arm(s): E-CAU with Group Problem Management Plus (PM+)
C: Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Collaborations in Health (COACH); Type: EXPERIMENTAL; Interventions: Behavioral: Collaborations in Health (COACH) | Intervention Type: BEHAVIORAL; Name: Collaborations in Health (COACH); Assigned to Arm(s): Collaborations in Health (COACH)
D: Arm Label: Sinovuyo Caring Families Programme; Type: EXPERIMENTAL; Interventions: Behavioral: Sinovuyo Caring Families Programme | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Sinovuyo Caring Families Programme; Assigned to Arm(s): Sinovuyo Caring Families Programme

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)
Brief Summary: The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 fatty acids; Assigned to Arm(s): 1, 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA Supplements | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA Supplements; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo Supplements; Assigned to Arm(s): 2
C: Arm Label: Omega-3 polyunsaturated fatty acids; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 polyunsaturated fatty acids | Arm Label: olive oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Olive oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 polyunsaturated fatty acids; Assigned to Arm(s): Omega-3 polyunsaturated fatty acids | Intervention Type: DIETARY_SUPPLEMENT; Name: Olive oil; Assigned to Arm(s): olive oil
D: Arm Label: Omega-3 Fish Oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 Fish Oil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 Fish Oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fish Oil; Assigned to Arm(s): Omega-3 Fish Oil, Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transcranial Direct Current Stimulation in Rehabilitation of Chronic Stroke Patients: Multicenter Clinical Trial
Brief Summary: In this study, the investigators wondered whether bihemispheric transcranial direct current stimulation (tDCS) would be capable to potentialize the effects of physical therapy on upper limb rehabilitation of chronic stroke patients. Moreover, the study aims to investigate the pattern of physiological variables involved in the recovery of these patients. For this purpose, patients included will be submitted to 10 sessions with active or sham bihemispheric tDCS associated with intensive and individual physical therapy session.


Options:
A: Arm Label: tDCS + physical therapy; Type: EXPERIMENTAL; Interventions: Device: tDCS + physical therapy | Arm Label: Sham tDCS + physical therapy; Type: SHAM_COMPARATOR; Interventions: Device: tDCS + physical therapy | Intervention Type: DEVICE; Name: tDCS + physical therapy; Assigned to Arm(s): Sham tDCS + physical therapy, tDCS + physical therapy
B: Arm Label: Transcranial direct current stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial direct current stimulation (tDCS) | Arm Label: ARM 2; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Intervention Type: DEVICE; Name: Transcranial direct current stimulation (tDCS); Assigned to Arm(s): Transcranial direct current stimulation | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): ARM 2
C: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: FAST protocol; Type: EXPERIMENTAL; Interventions: Behavioral: FAST protocol | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: FAST protocol; Assigned to Arm(s): FAST protocol
D: Arm Label: Upper limb motor function training + tDCS; Type: ACTIVE_COMPARATOR; Interventions: Device: transcranial direct current stimulation (tDCS) | Arm Label: upper limb motor function training + sham tDCS; Type: SHAM_COMPARATOR; Interventions: Device: transcranial direct current stimulation (tDCS) | Intervention Type: DEVICE; Name: transcranial direct current stimulation (tDCS); Assigned to Arm(s): Upper limb motor function training + tDCS, upper limb motor function training + sham tDCS

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transcranial Direct Current Stimulation in Rehabilitation of Chronic Stroke Patients: Multicenter Clinical Trial
Brief Summary: In this study, the investigators wondered whether bihemispheric transcranial direct current stimulation (tDCS) would be capable to potentialize the effects of physical therapy on upper limb rehabilitation of chronic stroke patients. Moreover, the study aims to investigate the pattern of physiological variables involved in the recovery of these patients. For this purpose, patients included will be submitted to 10 sessions with active or sham bihemispheric tDCS associated with intensive and individual physical therapy session.


Options:
A: Arm Label: tDCS + physical therapy; Type: EXPERIMENTAL; Interventions: Device: tDCS + physical therapy | Arm Label: Sham tDCS + physical therapy; Type: SHAM_COMPARATOR; Interventions: Device: tDCS + physical therapy | Intervention Type: DEVICE; Name: tDCS + physical therapy; Assigned to Arm(s): Sham tDCS + physical therapy, tDCS + physical therapy
B: Arm Label: CIMT + active anodal tDCS; Type: EXPERIMENTAL; Interventions: Device: active anodal transcranial Direct Current Stimulation (tDCS), Behavioral: Constraint Induced Movement Therapy (CIMT) | Arm Label: CIMT + sham tDCS; Type: SHAM_COMPARATOR; Interventions: Device: sham transcranial Direct Current Stimulation, Behavioral: Constraint Induced Movement Therapy (CIMT) | Arm Label: Healthy control subjects; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: active anodal transcranial Direct Current Stimulation (tDCS); Assigned to Arm(s): CIMT + active anodal tDCS | Intervention Type: DEVICE; Name: sham transcranial Direct Current Stimulation; Assigned to Arm(s): CIMT + sham tDCS | Intervention Type: BEHAVIORAL; Name: Constraint Induced Movement Therapy (CIMT); Assigned to Arm(s): CIMT + active anodal tDCS, CIMT + sham tDCS
C: Arm Label: subcortical; Type: EXPERIMENTAL; Interventions: Device: tDCS | Arm Label: cortical; Type: EXPERIMENTAL; Interventions: Device: tDCS | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): cortical, subcortical
D: Arm Label: transcranial direct current stim; Type: EXPERIMENTAL; Interventions: Device: transcranial direct current stim (tDCS) | Arm Label: sham tDCS; Type: PLACEBO_COMPARATOR; Interventions: Device: transcranial direct current stim (tDCS) | Intervention Type: DEVICE; Name: transcranial direct current stim (tDCS); Assigned to Arm(s): sham tDCS, transcranial direct current stim

Answer: A